Health · 3 views
Psilocybin Tied to Lower Inflammation in Parkinson's Trial
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 3 Community interest
Brief read Under 1 min brief 27 words
Summary
(MedPage Today) -- Markers of systemic inflammation and mitochondrial stress were reduced after psilocybin therapy in Parkinson's disease patients with mood dysfunction, a small nonrandomized trial showed.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- STAT+: CMS extends fraud crackdown to New York’s adult day care programContinue reading
- Invisible infrared light creates green letters that are less prone to blurContinue reading
- Ianalumab's Road to Approval for Sjogren's Looks BumpierContinue reading
- STI rates drop following antibiotic use recommendations for gay and bisexual menContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow